{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:12:24Z","timestamp":1776892344139,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jvir.2022.04.031","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:16:09Z","timestamp":1651317369000},"page":"926-933.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Chang-Hsien","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-I.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Chin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Abi-Jaoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lung-Hui","family":"Giiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shen","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2022.04.031_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2022.04.031_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.dld.2016.02.005","article-title":"Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: a meta-analysis","volume":"48","author":"Facciorusso","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jvir.2022.04.031_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184597","article-title":"Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: a network meta-analysis of randomized controlled trials","volume":"12","author":"Katsanos","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2022.04.031_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/bjc.1980.336","article-title":"Cytotoxicity of adriamycin to tumour cells in\u00a0vivo and in\u00a0vitro","volume":"42","author":"Martin","year":"1980","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2022.04.031_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/jnci\/81.16.1235","article-title":"Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia","volume":"81","author":"Wilson","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jvir.2022.04.031_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","article-title":"A\u00a0role for cancer stem cells in therapy resistance: cellular and molecular mechanisms","volume":"31","author":"Cojoc","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jvir.2022.04.031_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.06.006","article-title":"The bad seed: cancer stem cells in tumor development and resistance","volume":"28","author":"Koren","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jvir.2022.04.031_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.1993.220","article-title":"SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours","volume":"67","author":"Brown","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2022.04.031_bib10","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1200\/JCO.2005.01.3771","article-title":"Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003","volume":"23","author":"Williamson","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1200\/JCO.2013.51.4265","article-title":"Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study","volume":"32","author":"DiSilvestro","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib12","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1200\/JCO.2009.27.4449","article-title":"Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group","volume":"28","author":"Rischin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib13","doi-asserted-by":"crossref","first-page":"11937","DOI":"10.1073\/pnas.1613466113","article-title":"Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice","volume":"113","author":"Lin","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvir.2022.04.031_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00270-011-0156-4","article-title":"Enhanced antitumor effect of tirapazamine delivered intraperitoneally to VX2 liver tumor-bearing rabbits subjected to transarterial hepatic embolization","volume":"34","author":"Sonoda","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2022.04.031_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/JHC.S304275","article-title":"Phase I trial on arterial embolization with hypoxia activated tirapazamine for unresectable hepatocellular carcinoma","volume":"8","author":"Abi-Jaoudeh","year":"2021","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jvir.2022.04.031_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ajg.2009.654","article-title":"The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria","volume":"105","author":"Leoni","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2022.04.031_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cct.2015.09.019","article-title":"An integrated dose-finding tool for phase I trials in oncology","volume":"45","author":"Yang","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jvir.2022.04.031_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2214\/AJR.08.1285","article-title":"Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography","volume":"192","author":"Iwazawa","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2022.04.031_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jvir.2009.11.007","article-title":"Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization","volume":"21","author":"Tognolini","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.04.031_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2022.04.031_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2013.01.039","article-title":"Comparison of the methods for tumor\u00a0response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"58","author":"Jung","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2022.04.031_bib23","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","article-title":"EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization","volume":"55","author":"Gillmore","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2022.04.031_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/annonc\/mds605","article-title":"mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)","volume":"24","author":"Prajapati","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/bjc.2013.85","article-title":"A\u00a0randomised phase II\/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma","volume":"108","author":"Meyer","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2022.04.031_bib26","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2015.64.0821","article-title":"Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone","volume":"34","author":"Brown","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.04.031_bib27","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.3748\/wjg.v20.i37.13453","article-title":"Interventional treatment for unresectable hepatocellular carcinoma","volume":"20","author":"Murata","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvir.2022.04.031_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00270-009-9762-9","article-title":"Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model","volume":"33","author":"Liang","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2022.04.031_bib29","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3748\/wjg.v10.i19.2878","article-title":"Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvir.2022.04.031_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jvir.2016.11.037","article-title":"The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Pung","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.04.031_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of liver tumors with Lipiodol TACE: technical recommendations from experts opinion","volume":"39","author":"de Baere","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2022.04.031_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4254\/wjh.v6.i12.844","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: a review of techniques","volume":"6","author":"Imai","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jvir.2022.04.031_bib33","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/SLA.0b013e318295c160","article-title":"Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells","volume":"259","author":"Govaert","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2022.04.031_bib34","article-title":"Suppression of hypoxia-inducible factor\u00a01\u03b1 (HIF-1\u03b1) by tirapazamine is dependent on eIF2\u03b1 phosphorylation rather than the mTORC1\/4E-BP1 pathway","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2022.04.031_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044322008326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044322008326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:08:36Z","timestamp":1760940516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044322008326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1051044322008326"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2022.04.031","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2022.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2022","name":"copyright","label":"Copyright"}]}}